START Center Welcomes Dr. Navid Hafez to Drive Research Initiatives
Dr. Navid Hafez is set to spearhead the new early-phase research site at the Los Angeles Cancer Network, recognized as one of the largest and most diverse community-based oncology practices in the nation.
Recently, The START Center for Cancer Research, a preeminent community-based network focused on early-phase oncology trials, announced an important leadership change. Dr. Hafez has been appointed as Director of Clinical Research at their newly established clinic, START Los Angeles. In this role, he brings his vast expertise to enhance the clinic's research operations alongside Principal Investigator Dr. Lasika Seneviratne and a dedicated oncology research team.
Dr. Hafez's Impressive Background
Joining START Los Angeles, Dr. Hafez comes with over ten years of notable experience as both an academic and clinical investigator. His previous roles include serving as an attending physician at a renowned clinic affiliated with Cedars-Sinai and as an Assistant Professor of Medical Oncology at a prestigious university. His professional journey reflects strong leadership in investigator-initiated trials as well as sponsor-driven studies, making him a valuable asset to the team.
Expertise in Oncology Research
Dr. Hafez has significantly contributed to numerous Phase I and I/II studies, which have been pivotal in shaping contemporary oncology treatments. His involvement extends beyond trials; he has been an advocate for enhancing trial access, ensuring diverse patient enrollment, and integrating research seamlessly into clinical practice.
Start's Commitment to Oncology
Nick Slack, the Chairman and CEO of The START Center, highlighted Dr. Hafez’s exemplary qualities that align with the organization’s mission. "Dr. Hafez exemplifies the scientific rigor and patient-centered approach that define our network. His depth of knowledge boosts our capability to conduct complex development programs while ensuring patient access to groundbreaking therapies," Slack explained.
Fostering Patient Access to Care
Dr. Hafez underscored that the essence of early-phase oncology research revolves around access—a sentiment that resonates deeply with the foundation of START’s operational model. His vision is to cultivate a program in Los Angeles that effectively serves both patients and healthcare providers, aligning innovative research with accessible care.
Building a Groundbreaking Facility
The establishment of START Los Angeles marks a significant expansion of the START Network, now hosting a total of 15 sites. This new facility benefits from a partnership with Los Angeles Cancer Network, enabling an alignment with one of the largest community-based oncology practices in the country. With a patient population of over 14 million and around 100,000 new cancer diagnoses each year, the clinic presents exceptional prospects for providing advanced oncology trials to patients in a familiar care environment.
Los Angeles Cancer Network caters to over 14,000 new cancer patients annually, managing a comprehensive range of tumors which integrates research with treatment pathways. This collaboration enables patients to have direct access to innovative trials as part of their ongoing treatment plans.
About The START Center for Cancer Research
The START Center for Cancer Research is recognized worldwide for its commitment to community-centered oncology. With over 1,000 early-phase clinical trials conducted across its various sites, it showcases an unparalleled collection of principal investigators dedicated to accelerating clinical advancements. This focus on trials aims to transition innovative treatments into effective care, bringing hope to patients and their families.
About Los Angeles Cancer Network (Soon to Be Oncura Health)
As one of the nation's leading oncology practices, the Los Angeles Cancer Network, soon to be known as Oncura Health, is redefining community cancer care by combining comprehensive medical services with compassionate patient support. Oncura Health is committed to addressing the entire spectrum of a patient’s journey, from diagnosis through treatment.
Contact START for More Information
For additional details, please contact Lauren Panco, VP of Marketing, at 609-216-4920.
Frequently Asked Questions
Who is Dr. Navid Hafez?
Dr. Hafez is the newly appointed Director of Clinical Research at START Los Angeles, bringing extensive experience in oncology research and clinical trials.
What is the role of START Los Angeles?
START Los Angeles focuses on early-phase oncology research, providing patients with access to the latest innovative therapies in a community setting.
How many sites are in the START Network?
START Los Angeles represents the 15th site in the START Network, all dedicated to advancing cancer research and treatment.
What are the services provided by Los Angeles Cancer Network?
The Los Angeles Cancer Network offers comprehensive oncology services, including medical oncology, hematology, and surgical services.
What impact does Dr. Hafez have on the research community?
Dr. Hafez's leadership enhances the START Network’s capabilities in executing complex studies while increasing patient access to cutting-edge treatment options.
